Treatment of hyperemesis gravidarum with the 5-HT3 antagonist ondansetron (Zofran)

55Citations
Citations of this article
35Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Ondansetron is a 5-hydroxytryptamine receptor antagonist which is known to be a highly effective anti-emetic drug for chemotherapy-associated nausea and vomiting and for postoperative nausea. We report here a case where ondansetron was used in severe hyperemesis gravidarum to avoid parenteral nutrition. The drug was used intermittently in every trimester with no apparent adverse effects on mother or infant.

Cite

CITATION STYLE

APA

Tincello, D. G. (1996). Treatment of hyperemesis gravidarum with the 5-HT3 antagonist ondansetron (Zofran). Postgraduate Medical Journal, 72(853), 688–689. https://doi.org/10.1136/pgmj.72.853.688

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free